This section provides you information about the WMDA Working Groups and Committees that have regular meetings and develop recommendations for the WMDA Standards.

Introduction

The WMDA provides a forum for mutual discussion of all issues pertinent to the clinical use of stem cells from unrelated donors. The goals are achieved through a comprehensive system of working groups and committees, each comprised of individuals of the WMDA community, with specific expertise in transplantation, immunology, HLA, hematology and other related fields.

The Working Groups/Committees are responsible for developing the described WMDA initiatives. They are concerned with recommending the best practice in terms of the medical, ethical, technical, quality and financial aspects of international hematopoietic stem cell transplantation. Within the WMDA the following Working Groups/Committees are active:

WMDA Working Groups

• Clinical Working Group
• Cord Blood Working Group
• Donor Registries Working Group
• Ethics Working Group
• Information Technology Working Group
• Quality Assurance Working Group

WMDA Board Committees

• Education Committee
• Regulatory and Legal Affairs
• S(P)EAR Committee

WMDA Regional Initiatives of Registries

• Asian Registries
• Group of Median Size European Registries